PharmaLeaders published “The Role of AI in Precision Medicine: The Right Drug for the Right Patient at the Right Time,” featuring AiCure’s Chief Medical Officer, Rich Christie, in a forward-looking piece on AI’s unique potential to transform drug development through precision medicine by delivering the timely, accurate behavioral insights needed to drive informed interventions, understand which patients will be able to contribute quality data for specific studies, and bridge clinical findings in an increasingly diverse real-world environment.
Sep 07, 2022
AiCure Launches Site Services to Reduce Burden and Optimize Research Operations for Clinical Sites
Jul 12, 2022
AiCure and Defense Health Agency to Develop Targeted PTSD Treatment for Service Members and Veterans
Jun 06, 2022
Demystifying Machine Learning: Why Transparency Will Lead to Trust
- Sep 07, 2022